House lawmakers passed a bipartisan-backed spending bill Thursday that will fund HHS and community health centers through the end of September, and crack down on pharmacy benefit managers.
The U.S. House overwhelmingly approved a bipartisan-backed spending bill Thursday that will fund the Department of Health and Human Services [...]
Please Login or Become a Paid Subscriber to View this Content
HRSA recently announced that a 340B ADR panel had rejected two hospitals' petition challenging Novo Nordisk's contract pharmacy restrictions.
The latest decision under the federal government’s revamped 340B Administrative Dispute Resolution (ADR) process once again sided with drugmakers, dealing [...]
Please Login or Become a Paid Subscriber to View this Content
AstraZeneca filed a federal lawsuit challenging New Mexico's health center 340B contract pharmacy access law.
AstraZeneca recently launched the third pharmaceutical industry challenge to New Mexico’s law that prohibits drugmakers from placing 340B contract pharmacy [...]
Please Login or Become a Paid Subscriber to View this Content
HRSA announced that four covered entities were terminated from the 340B program and indicated that they made purchases when they were not eligible to do so.
The Health Resources and Services Administration (HRSA) recently announced that four covered entities were terminated from the 340B program and [...]
Please Login or Become a Paid Subscriber to View this Content
House Appropriations Committee Democrats on Jan. 20 shared a "joint explanatory statement," which noted that "the agreement is concerned that HRSA's proposed 340B rebate model pilot program could increase costs for patients or limit access to their prescriptions."
Congressional leaders reached a bipartisan health care agreement Tuesday that will fund Health Resources and Services Administration (HRSA) activities through [...]
Please Login or Become a Paid Subscriber to View this Content
Johnson & Johnson recently updated its Pharmaceutical Manufacturer Configuration, which details how industry vendor Beacon Channel Management must process MFP rebates in 2026.
A major drugmaker selected to take part in the Health Resources and Services Administration’s (HRSA) 340B rebate model recently announced [...]
Please Login or Become a Paid Subscriber to View this Content